miR-210-3p Promotes Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance by Targeting SOCS1-Mediated NF-κB Pathway
Diabetes · 01.03.2023 · 72 (3) · 375-388
DOI: 10.2337/db22-0284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 05.12.2022. Verfasst von Debarun Patra und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Indian Institute of Technology Ropar, Punjab, India. Hauptthemen laut MEDLINE: MicroRNAs, Insulin Resistance, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, Science and Engineering Research Board.
Abstract (Originalsprache)
Under the condition of chronic obesity, an increased level of free fatty acids along with low oxygen tension in the adipose tissue creates a pathophysiological adipose tissue microenvironment (ATenv), leading to the impairment of adipocyte function and insulin resistance. Here, we found the synergistic effect of hypoxia and lipid (H + L) surge in fostering adipose tissue macrophage (ATM) inflammation and polarization. ATenv significantly increased miR-210-3p expression in ATMs which promotes NF-κB activation–dependent proinflammatory cytokine expression along with the downregulation of anti-inflammatory cytokine expression. Interestingly, delivery of miR-210-3p mimic significantly increased macrophage inflammation in the absence of H + L co-stimulation, while miR-210-3p inhibitor notably compromised H + L–induced macrophage inflammation through increased production of suppressor of cytokine signaling 1 (SOCS1), a negative regulator of the NF-κB inflammatory signaling pathway. Mechanistically, miR-210 directly binds to the 3′-UTR of SOCS1 mRNA and silences its expression, thus preventing proteasomal degradation of NF-κB p65. Direct delivery of anti–miR-210-3p LNA in the ATenv markedly rescued mice from obesity-induced adipose tissue inflammation and insulin resistance. Thus, miR-210-3p inhibition in ATMs could serve as a novel therapeutic strategy for managing obesity-induced type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Indian Institute of Technology Ropar, Punjab, India.
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Sahibzada Ajit Singh Nagar, Punjab, India.
- Department of Gastro Surgery, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.
- Department of Molecular Biology and Biotechnology, Tezpur University, Assam, India.
ORCID-Profile: Suman Dasgupta, Kulbhushan Tikoo, Durba Pal
Förderung
- Department of Biotechnology, Ministry of Science and Technology
- Science and Engineering Research Board
Zitieren
APA
Patra, D., Roy, S., Arora, L., Kabeer, S. W., Singh, S., Dey, U., Banerjee, D., Sinha, A., Dasgupta, S., Tikoo, K., Kumar, A., & Pal, D. (2023). miR-210-3p Promotes Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance by Targeting SOCS1-Mediated NF-κB Pathway. Diabetes, 72(3), 375-388. https://doi.org/10.2337/db22-0284
Vancouver
Patra D, Roy S, Arora L, Kabeer SW, Singh S, Dey U, et al. miR-210-3p Promotes Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance by Targeting SOCS1-Mediated NF-κB Pathway. Diabetes. 2023;72(3):375-388. doi:10.2337/db22-0284
BibTeX
@article{Patra2023,
author = {Patra, Debarun and Roy, Soumyajit and Arora, Leena and Kabeer, Shaheen Wasil and Singh, Satpal and Dey, Upalabdha and Banerjee, Dipanjan and Sinha, Archana and Dasgupta, Suman and Tikoo, Kulbhushan and Kumar, Aditya and Pal, Durba},
title = {miR-210-3p Promotes Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance by Targeting SOCS1-Mediated NF-κB Pathway},
journal = {Diabetes},
year = {2023},
volume = {72},
number = {3},
pages = {375--388},
doi = {10.2337/db22-0284}
}
EUVIMED